These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 20666266)
21. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience. Singh-Grewal D; Wong M; Isaacs D J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066 [TBL] [Abstract][Full Text] [Related]
22. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm. Michihata N; Matsui H; Fushimi K; Yasunaga H Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948 [TBL] [Abstract][Full Text] [Related]
23. The many faces of Kawasaki syndrome. Leung DY; Meissner HC Hosp Pract (1995); 2000 Jan; 35(1):77-81, 85-6, 91-4. PubMed ID: 10645991 [TBL] [Abstract][Full Text] [Related]
24. Management of Kawasaki disease in the British Isles. Dhillon R; Newton L; Rudd PT; Hall SM Arch Dis Child; 1993 Dec; 69(6):631-6; discussion 637-8. PubMed ID: 8285773 [TBL] [Abstract][Full Text] [Related]
25. [Kawasaki disease in Iceland 1996-2005, epidemiology and complications]. Olafsdottir HS; Oskarsson G; Haraldsson Á Laeknabladid; 2012 Feb; 98(2):91-5. PubMed ID: 22314510 [TBL] [Abstract][Full Text] [Related]
26. Cardiovascular involvement in Kawasaki disease. Narayanan SN; Ahamed MZ; Safia M Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of kawasaki disease. Saguil A; Fargo M; Grogan S Am Fam Physician; 2015 Mar; 91(6):365-71. PubMed ID: 25822554 [TBL] [Abstract][Full Text] [Related]
28. [Clinical manifestations and effects of IVGG in patients with Kawasaki disease]. Hwang KP; Wu JR; Huang LY; Liou CC; Huang TY Kaohsiung J Med Sci; 1996 Mar; 12(3):159-66. PubMed ID: 8709183 [TBL] [Abstract][Full Text] [Related]
34. Kawasaki disease in Jordan: demographics, presentation, and outcome. Al-Ammouri I; Al-Wahsh S; Khuri-Bulos N Cardiol Young; 2012 Aug; 22(4):390-5. PubMed ID: 22067065 [TBL] [Abstract][Full Text] [Related]
35. Retropharyngeal involvement in Kawasaki disease--a report of four patients with retropharyngeal edema verified by magnetic resonance imaging. Puhakka L; Saat R; Klockars T; Kajosaari L; Salo E; Nieminen T Int J Pediatr Otorhinolaryngol; 2014 Oct; 78(10):1774-8. PubMed ID: 25081603 [TBL] [Abstract][Full Text] [Related]
36. Strengthening the case for primary adjunctive corticosteroids for Kawasaki disease. Renton WD; Ramanan AV Arch Dis Child; 2021 Mar; 106(3):209-210. PubMed ID: 33272947 [No Abstract] [Full Text] [Related]
37. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study]. Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453 [TBL] [Abstract][Full Text] [Related]
38. Evidence-based management of Kawasaki disease in the emergency department. Seaton KK; Kharbanda A Pediatr Emerg Med Pract; 2015 Jan; 12(1):1-20; quiz 21. PubMed ID: 25693305 [TBL] [Abstract][Full Text] [Related]